SCHEMBL22734816

SCHEMBL22734816

O=COC(=O)c1cccc(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.53
▸ HPGD P15428 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ GAA P10253 1/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ NFKB2 Q00653 1/20 0.51
▸ RELA Q04206 1/20 0.51
▸ CYP1A2 P05177 1/20 0.50
▸ MAPK1 P28482 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ LMNA P02545 2/20 0.48
▸ TSHR P16473 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.47
▸ TP53 P04637 1/20 0.47
▸ MAPT P10636 3/20 0.47
▸ PTPN1 P18031 2/20 0.46
▸ C1S P09871 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL556974 0.88 TDP1 (0.44) MAPK1LMNATSHRALDH1A1TP53
SCHEMBL3623562 0.84 PARP1 (0.52) PARP1HPGDSMN1; SMN2GAANFKB1
SCHEMBL25295747 0.81 UNG (0.55) HPGDCYP1A2KDM4ETSHRALDH1A1
SCHEMBL7655031 0.80 PARP1 (0.61) PARP1HPGDSMN1; SMN2GAANFKB1
SCHEMBL5488346 0.80 PARP1 (0.61) PARP1HPGDSMN1; SMN2GAANFKB1
SCHEMBL27541340 0.79 TSHR (0.55) SMN1; SMN2TSHRALDH1A1TP53NPC1
SCHEMBL247378 0.79 PARP1 (0.64) PARP1HPGDSMN1; SMN2GAANFKB1
Acetic Acid SCHEMBL27798910 0.78 SMN1; SMN2 (0.49) PARP1HPGDSMN1; SMN2GAANFKB1
SCHEMBL22734773 0.78 PARP1 (0.53) PARP1HPGDSMN1; SMN2GAANFKB1
SCHEMBL28999822 0.78 HCRTR1 (0.41) PTPN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114956933-A Marker containing isotope oxygen atom and preparation method and application thereof 清华大学 2022-08-30 — — CN disclosed
CN-114920706-A Method for preparing 3-acyl-quinoxaline-2 (1H) -ketone by ball milling method 新乡市润宇新材料科技有限公司 2022-08-19 — — CN disclosed
US-20200385328-A1 METHOD FOR PRODUCING BENZOYL FORMIC ACID COMPOUND AND PYRIDAZINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-12-10 — — US disclosed
CN-108101856-B Preparation method of acyl-substituted pyrazine compound HENAN AGRICULTURAL UNIVERSITY (CN) 2019-12-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200385328-A1 METHOD FOR PRODUCING BENZOYL FORMIC ACID COMPOUND AND PYRIDAZINE COMPOUND SDHA, FDPS, NDUFS5 PARP1 1104/4885HPGD 26/4885SMN1; SMN2 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback